Actively Recruiting
Temporal Interference Stimulation for Social Cognition
Led by Columbia University · Updated on 2026-04-23
10
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
C
Columbia University
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The long-term goal of this project is to evaluate whether a procedure termed transcranial interference stimulation (tIS) may be useful in the future in the treatment of severe neuropsychiatric disorders such as schizophrenia. The purpose of this stage of the project is to evaluate the safety and tolerability of tIS administration in healthy volunteers. This study involves 10 healthy participants without known psychiatric illness X 3 successive doses. Participants may participate in 1-3 doses, yielding a total sample size of 10-30 individuals across doses. The dose of tIS will be escalated progressively across doses. Functional magnetic resonance imaging (fMRI), magnetic resonance spectroscopy (MRS) and side effect checklists will be used to assess tIS safety/tolerability at each dose. In addition, electroencephalogram (EEG) will be collected simultaneously with tIS and used to assess target engagement. Face emotion recognition (FER) data will also be collected, but will be used for feasibility assessment only. If successful, these studies will form the basis for future studies in schizophrenia.
CONDITIONS
Official Title
Temporal Interference Stimulation for Social Cognition
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female
- Age 18-55 years
- Intelligence quotient (IQ) above 70 on the Wechsler Adult Intelligence Scale (WAIS)
- Able and willing to provide informed consent
- No standing use of medications for psychiatric disorders or certain nervous system drugs within 90 days
- Intermittent use of sedative/hypnotics allowed but not within 48 hours before tIS
- Healthy based on medical history and physical exam within 90 days of enrollment
You will not qualify if you...
- Any illness or condition that may interfere with study completion or affect data quality
- Contraindications to MRI such as metal implants, claustrophobia, or pregnancy
- Moderate to high suicide risk based on Columbia-Suicide Severity Rating Scale responses
- Significant medical illnesses including abnormal blood pressure, cardiac illness, or abnormal ECG
- Women of childbearing potential who are pregnant, not using effective contraception, or planning pregnancy during study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Columbia University Irving Medical Center/NewYork-Presbyterian Hospital (CUIMC/NYPH)
New York, New York, United States, 10032
Actively Recruiting
Research Team
D
Daniel C Javitt, M.D., Ph.D.
CONTACT
P
Pejman Sehatpour, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here